Prof. Dr. Werner Albrich
Leitende(r) Arzt/Ärztin
Infektiologie | Infektionsprävention | Reisemedizin · Dept. I
Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial.
Darie A, Khanna N, Jahn K, Osthoff M, Bassetti S, Osthoff M, Schumann D, Albrich W, Hirsch H, Brutsche M, Grize L, Tamm M, Stolz D. Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial. Lancet Respir Med 2022; 10:877-887.
23.05.2022Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial.
23.05.2022Lancet Respir Med 2022; 10:877-887
Darie Andrei M, Khanna Nina, Jahn Kathleen, Osthoff Michael, Bassetti Stefano, Osthoff Mirjam, Schumann Desiree M, Albrich Werner, Hirsch Hans, Brutsche Martin, Grize Leticia, Tamm Michael, Stolz Daiana
Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis.
Fischer T, El Baz Y, Graf N, Wildermuth S, Leschka S, Kleger G, Pietsch U, Frischknecht M, Scanferla G, Strahm C, Wälti S, Dietrich T, Albrich W. Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis. Diagnostics (Basel) 2022; 12
11.05.2022Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis.
11.05.2022Diagnostics (Basel) 2022; 12
Fischer Tim, El Baz Yassir, Graf Nicole, Wildermuth Simon, Leschka Sebastian, Kleger Gian-Reto, Pietsch Urs, Frischknecht Manuel, Scanferla Giulia, Strahm Carol, Wälti Stephan, Dietrich Tobias, Albrich Werner
Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series.
Rüfenacht S, Gantenbein P, Boggian K, Flury D, Kern L, Dollenmaier G, Kohler P, Albrich W. Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series. Infection 2022; 50:783-790.
15.04.2022Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series.
15.04.2022Infection 2022; 50:783-790
Rüfenacht Susanne, Gantenbein Pascal, Boggian Katia, Flury Domenica, Kern Lukas, Dollenmaier Günter, Kohler Philipp, Albrich Werner
Whole-genome sequencing reveals host factors underlying critical COVID-19.
Kousathanas A, Pairo-Castineira E, Rawlik K, Stuckey A, Odhams C, Walker S, Russell C, Malinauskas T, Wu Y, Millar J, Shen X, Elliott K, Griffiths F, Oosthuyzen W, Morrice K, Keating S, Wang B, Rhodes D, Klaric L, Zechner M, Parkinson N, Siddiq A, Goddard P, Donovan S, Maslove D, Nichol A, Semple M, Zainy T, Maleady-Crowe F, Todd L, Salehi S, Knight J, Elgar G, Chan G, Arumugam P, Patch C, Rendon A, Bentley D, Kingsley C, Kosmicki J, Horowitz J, Baras A, Abecasis G, Ferreira M, Justice A, Mirshahi T, Oetjens M, Rader D, Ritchie M, Verma A, Fowler T, Shankar-Hari M, Summers C, Hinds C, Horby P, Ling L, McAuley D, Montgomery H, Openshaw P, Elliott P, Walsh T, Tenesa A, Fawkes A, Murphy L, Rowan K, Ponting C, Vitart V, Wilson J, Yang J, Bretherick A, Scott R, Hendry S, Moutsianas L, Law A, Caulfield M, Baillie J, Albrich W. Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature 2022; 607:97-103.
07.03.2022Whole-genome sequencing reveals host factors underlying critical COVID-19.
07.03.2022Nature 2022; 607:97-103
Kousathanas Athanasios, Pairo-Castineira Erola, Rawlik Konrad, Stuckey Alex, Odhams Christopher A, Walker Susan, Russell Clark D, Malinauskas Tomas, Wu Yang, Millar Jonathan, Shen Xia, Elliott Katherine S, Griffiths Fiona, Oosthuyzen Wilna, Morrice Kirstie, Keating Sean, Wang Bo, Rhodes Daniel, Klaric Lucija, Zechner Marie, Parkinson Nick, Siddiq Afshan, Goddard Peter, Donovan Sally, Maslove David, Nichol Alistair D, Semple Malcolm G, Zainy Tala, Maleady-Crowe Fiona, Todd Linda, Salehi Shahla, Knight Julian, Elgar Greg, Chan Georgia, Arumugam Prabhu, Patch Christine, Rendon Augusto, Bentley David, Kingsley Clare, Kosmicki Jack A, Horowitz Julie E, Baras Aris, Abecasis Gonçalo R, Ferreira Manuel A R, Justice Anne E, Mirshahi Tooraj, Oetjens Matthew, Rader Daniel J, Ritchie Marylyn D, Verma Anurag, Fowler Tom A, Shankar-Hari Manu, Summers Charlotte, Hinds Charles, Horby Peter, Ling Lowell, McAuley Danny, Montgomery Hugh, Openshaw Peter J M, Elliott Paul, Walsh Timothy, Tenesa Albert, Fawkes Angie, Murphy Lee, Rowan Kathy, Ponting Chris P, Vitart Veronique, Wilson James F, Yang Jian, Bretherick Andrew D, Scott Richard H, Hendry Sara Clohisey, Moutsianas Loukas, Law Andy, Caulfield Mark J, Baillie J Kenneth, Albrich Werner
Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19.
Sadlier C, Albrich W, Neogi U, Lunjani N, Horgan M, O'Toole P, O'Mahony L. Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19. Allergy 2022; 77:1623-1625.
17.02.2022Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19.
17.02.2022Allergy 2022; 77:1623-1625
Sadlier Corinna, Albrich Werner, Neogi Ujjwal, Lunjani Nonhlanhla, Horgan Mary, O'Toole Paul W, O'Mahony Liam
Early post-discharge mortality in CAP: frequency, risk factors and a prediction tool.
Glöckner V, Pletz M, Rohde G, Rupp J, Witzenrath M, Barten-Neiner G, Kolditz M, Albrich W. Early post-discharge mortality in CAP: frequency, risk factors and a prediction tool. Eur J Clin Microbiol Infect Dis 2022; 41:621-630.
08.02.2022Early post-discharge mortality in CAP: frequency, risk factors and a prediction tool.
08.02.2022Eur J Clin Microbiol Infect Dis 2022; 41:621-630
Glöckner Verena, Pletz Mathias W, Rohde Gernot G U, Rupp Jan, Witzenrath Martin, Barten-Neiner Grit, Kolditz Martin, Albrich Werner
No evidence of harmful effects of steroids in severe exacerbations of COPD associated with influenza.
Studer S, Rassouli F, Waldeck F, Brutsche M, Baty F, Albrich W. No evidence of harmful effects of steroids in severe exacerbations of COPD associated with influenza. Infection 2022; 50:699-707.
29.01.2022No evidence of harmful effects of steroids in severe exacerbations of COPD associated with influenza.
29.01.2022Infection 2022; 50:699-707
Studer Severin, Rassouli Frank, Waldeck Frederike, Brutsche Martin H, Baty Florent, Albrich Werner
Higher levels of bacterial DNA in serum associate with severe and fatal COVID-19.
Lunjani N, Albrich W, Suh N, Barda B, Finnegan L, Dam S, Walter J, Sadlier C, Horgan M, O'Toole P, O'Mahony L. Higher levels of bacterial DNA in serum associate with severe and fatal COVID-19. Allergy 2022; 77:1312-1314.
22.01.2022Higher levels of bacterial DNA in serum associate with severe and fatal COVID-19.
22.01.2022Allergy 2022; 77:1312-1314
Lunjani Nonhlanhla, Albrich Werner, Suh Noémie, Barda Beatrice, Finnegan Laura A, Dam Sarita A, Walter Jens, Sadlier Corinna, Horgan Mary, O'Toole Paul W, O'Mahony Liam
The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).
König R, Albrich W, Kahlert C, Bahr L, Löber U, Vernazza P, Scheibenbogen C, Forslund S. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS). Front Immunol 2022; 12:628741.
03.01.2022The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).
03.01.2022Front Immunol 2022; 12:628741
König Rahel S, Albrich Werner, Kahlert Christian, Bahr Lina Samira, Löber Ulrike, Vernazza Pietro, Scheibenbogen Carmen, Forslund Sofia K
A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2.
Albrich W, Ghosh T, Ahearn-Ford S, Mikaeloff F, Lunjani N, Forde B, Suh N, Kleger G, Pietsch U, Frischknecht M, Garzoni C, Forlenza R, Horgan M, Sadlier C, Negro T, Pugin J, Wozniak H, Cerny A, Neogi U, O'Toole P, O'Mahony L. A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2. Gut Microbes 2022; 14:2073131.
01.01.2022A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2.
01.01.2022Gut Microbes 2022; 14:2073131
Albrich Werner, Ghosh Tarini Shankar, Ahearn-Ford Sinead, Mikaeloff Flora, Lunjani Nonhlanhla, Forde Brian, Suh Noémie, Kleger Gian-Reto, Pietsch Urs, Frischknecht Manuel, Garzoni Christian, Forlenza Rossella, Horgan Mary, Sadlier Corinna, Negro Tommaso Rochat, Pugin Jérôme, Wozniak Hannah, Cerny Andreas, Neogi Ujjwal, O'Toole Paul W, O'Mahony Liam
[Non-antibiotic Prophylaxis of Infections].
Seneghini M, Albrich W. [Non-antibiotic Prophylaxis of Infections]. Praxis (Bern 1994) 2022; 111:463-468.
01.01.2022[Non-antibiotic Prophylaxis of Infections].
01.01.2022Praxis (Bern 1994) 2022; 111:463-468
Seneghini Marco, Albrich Werner
Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer.
Bösch M, Baty F, Albrich W, Flatz L, Rodriguez R, Rothschild S, Jörger M, Früh M, Brutsche M. Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer. Oncoimmunology 2021; 10:1988403.
10.12.2021Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer.
10.12.2021Oncoimmunology 2021; 10:1988403
Bösch Maximilian, Baty Florent, Albrich Werner, Flatz Lukas, Rodriguez Regulo, Rothschild Sacha I, Jörger Markus, Früh Martin, Brutsche Martin H
Digital SARS-CoV-2 Detection Among Hospital Employees: Participatory Surveillance Study
Leal-Neto O, Kahlert C, Vernazza P, Kuster S, Babouee Flury B, Albrich W, Sumer J, Flury D, Schlegel M, Egger T, Kohler P. Digital SARS-CoV-2 Detection Among Hospital Employees: Participatory Surveillance Study. JMIR Public Health Surveill 2021; 7:e33576.
22.11.2021Digital SARS-CoV-2 Detection Among Hospital Employees: Participatory Surveillance Study
22.11.2021JMIR Public Health Surveill 2021; 7:e33576
Leal-Neto Onicio, Kahlert Christian, Vernazza Pietro, Kuster Stefan, Babouee Flury Baharak, Albrich Werner, Sumer Johannes, Flury Domenica, Schlegel Matthias, Egger Thomas, Kohler Philipp
Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
Hasan Ali O, Bomze D, Risch L, Brugger S, Paprotny M, Weber M, Thiel S, Kern L, Albrich W, Kohler P, Kahlert C, Vernazza P, Bühler P, Schüpbach R, Gómez-Mejia A, Popa A, Bergthaler A, Penninger J, Flatz L. Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin Infect Dis 2021; 73:1746.
02.11.2021Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
02.11.2021Clin Infect Dis 2021; 73:1746
Hasan Ali Omar, Bomze David, Risch Lorenz, Brugger Silvio D, Paprotny Matthias, Weber Myriam, Thiel Sarah, Kern Lukas, Albrich Werner, Kohler Philipp, Kahlert Christian, Vernazza Pietro, Bühler Philipp K, Schüpbach Reto A, Gómez-Mejia Alejandro, Popa Alexandra M, Bergthaler Andreas, Penninger Josef M, Flatz Lukas
Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018
Barnsteiner S, Kohler P, Kronenberg A, Schlegel M, Plüss-Suard C, Gasser M, Babouee Flury B, Albrich W, Baty F, Swiss Centre for Antibiotic Resistance (ANRESIS). Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018. Euro Surveill 2021; 26
01.11.2021Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018
01.11.2021Euro Surveill 2021; 26
Barnsteiner Stefanie, Kohler Philipp, Kronenberg Andreas, Schlegel Matthias, Plüss-Suard Catherine, Gasser Michael, Babouee Flury Baharak, Albrich Werner, Baty Florent, Swiss Centre for Antibiotic Resistance (ANRESIS)
Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses
Schmiedeberg K, Vuilleumier N, Pagano S, Albrich W, Ludewig B, von Kempis J, Rubbert-Roth A. Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses. Lancet Rheumatol 2021; 4:e11-e13.
26.10.2021Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses
26.10.2021Lancet Rheumatol 2021; 4:e11-e13
Schmiedeberg Kristin, Vuilleumier Nicolas, Pagano Sabrina, Albrich Werner, Ludewig Burkhard, von Kempis Johannes, Rubbert-Roth Andrea
[50/m-Headache, cough and myalgia : Preparation for the medical specialist examination: part 88]
Seneghini M, Albrich W. [50/m-Headache, cough and myalgia : Preparation for the medical specialist examination: part 88]. Internist (Berl) 2021; 62:571-574.
17.08.2021[50/m-Headache, cough and myalgia : Preparation for the medical specialist examination: part 88]
17.08.2021Internist (Berl) 2021; 62:571-574
Seneghini Marco, Albrich Werner
Clinical outcomes of adults hospitalized for laboratory confirmed respiratory syncytial virus or influenza virus infection
Chorazka M, Flury D, Herzog K, Albrich W, Vuichard-Gysin D. Clinical outcomes of adults hospitalized for laboratory confirmed respiratory syncytial virus or influenza virus infection. PloS one 2021; 16:e0253161.
22.07.2021Clinical outcomes of adults hospitalized for laboratory confirmed respiratory syncytial virus or influenza virus infection
22.07.2021PloS one 2021; 16:e0253161
Chorazka Magdalena, Flury Domenica, Herzog Kathrin, Albrich Werner, Vuichard-Gysin Danielle
Molecular Epidemiology and Risk Factors for Extended-Spectrum β-Lactamase-Producing Enterobacterales in Long-Term Care Residents
Kohler P, Egli A, Petignat C, Schlegel M, Münzer T, Harbarth S, Gardiol C, Babouee Flury B, Albrich W, Seth-Smith H, Nolte O, Qalla Widmer L, Lemmenmeier E, Rettenmund G, Kessler S, Seiffert S, Héquet D. Molecular Epidemiology and Risk Factors for Extended-Spectrum β-Lactamase-Producing Enterobacterales in Long-Term Care Residents. J Am Med Dir Assoc 2021
21.07.2021Molecular Epidemiology and Risk Factors for Extended-Spectrum β-Lactamase-Producing Enterobacterales in Long-Term Care Residents
21.07.2021J Am Med Dir Assoc 2021
Kohler Philipp, Egli Adrian, Petignat Christiane, Schlegel Matthias, Münzer Thomas, Harbarth Stephan, Gardiol Céline, Babouee Flury Baharak, Albrich Werner, Seth-Smith Helena M B, Nolte Oliver, Qalla Widmer Laetitia, Lemmenmeier Eva, Rettenmund Gabriela, Kessler Simone, Seiffert Salome N, Héquet Delphine
[58/m-fever, cough and severe hypoxemia : Preparation for the medical specialist examination: part 65]
Seneghini M, Albrich W. [58/m-fever, cough and severe hypoxemia : Preparation for the medical specialist examination: part 65]. Internist (Berl) 2021; 62:435-439.
15.07.2021[58/m-fever, cough and severe hypoxemia : Preparation for the medical specialist examination: part 65]
15.07.2021Internist (Berl) 2021; 62:435-439
Seneghini Marco, Albrich Werner